A carregar...
The journey to CAR T cell therapy: the pediatric and young adult experience with relapsed or refractory B-ALL
Outcomes of pediatric and young adult patients diagnosed with acute lymphoblastic leukemia (ALL) have improved significantly in the past few decades. Treatment advances have provided 5-year survival rates ranging from 78 to 91% depending on the age at diagnosis. However, approximately 2–3% of patien...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342933/ https://ncbi.nlm.nih.gov/pubmed/30670684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-018-0164-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|